The World Health Organization has recommended the inclusion of two experimental vaccines in an ongoing clinical trial, according to Capital FM. The vaccines are specifically designed to protect against the Bundibugyo strain of Ebola.
The recommendation involves adding the experimental vaccines to a trial already in progress. The Bundibugyo strain is one of several types of Ebola virus.
Source: Capital FM